Navigation Links
Two New Strategic Reports Expand Coverage Of BioTrend's Biosimilars Advisory Service
Date:4/1/2013

EXTON, Pa., April 1, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released two strategic components to its 2013 Biosimilars Advisory Service, which provides vital business planning insights and analysis in the evolving biosimilars space. The reports entitled Corporate Strategies and Global Pipelines, Pathways and Key Stakeholder Perspectives of Biosimilars analyze surveyed opinions of specialist physicians and payers in the United States and Europe and secondary market research to uncover critical trends in strategic development for commercially lucrative market segments.

"The Biosimilars Advisory Service has always been a highly valuable tool for understanding trends in a complex and dynamic market," said Andrew Merron , Ph.D., Senior Director, Biosimilars Research at Decision Resources Group. "These new reports aim to enhance the overall service by evaluating current market opinion to help understand globally focused business strategies, regulatory guidance in multiple markets and pipeline information."

BioTrends Research Group's Biosimilars Advisory Service also includes quarterly webinars detailing major industry developments, analyst insight addressing key market changes, therapeutic area-specific primary research and interactive annualized 10-year forecasts.

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.Bio-Trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

 For more information, contact:BioTrends Research Group Decision Resources GroupAllison Thrower

Liz Marshall781-993-2604

781-993-2563athrower@dresourcesgroup.com

emarshall@dresourcesgroup.com


'/>"/>
SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuro Intervention Market: New Strategic Landscape & Market Forecast
2. MDHI Receives Strategic Investment to Continue Strong Growth - Moves into Positive Operating Cash Flow for March 2013 Quarter
3. Saladax Biomedical Receives $22.4 Million Strategic Equity Investment From Shanghai Fosun Pharmaceutical
4. DDS Lab Announces Strategic Alliance with United Concordia
5. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
6. Evofem Announces Strategic Alliance with WomanCare Global
7. WebMD and Qualcomm Life Launch Strategic mHealth Collaboration
8. Imalux Corporation Engages Advisor to Explore Strategic Options
9. BioDrain Medical Retains KCSA Strategic Communications as Corporate Communications Counsel
10. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
11. Covaris and HORIBA Instruments Form Strategic Relationship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
(Date:5/25/2016)... , May 25, 2016 MedDay, ... disorders, announces that an oral presentation entitled "High doses of ... MS-SPI trial" will be given by Professor Ayman Tourbah ... 2nd Congress of the European Academy of Neurology (EAN) in ... and related disorders 3" will take place on Sunday, 29 ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology:
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... the factors of a stroke, which we as a society can control and change. ... a stroke occurs nearly every 40 seconds within the United States. Plus, with an ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... to help educate the many who are unaware of the plight of aphasia. ... will run within the “Stroke Awareness” campaign. , The link between stroke and ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... interest stories, courtesy of leaders in the nursing and health care industry. It ... leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning ...
Breaking Medicine News(10 mins):